Search Results - "Klepper, M J"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    The periodic safety update report as a pharmacovigilance tool by Klepper, Michael J

    Published in Drug safety (01-01-2004)
    “…The periodic safety update report for marketed drugs (PSUR) was designed to be a stand-alone document that allows a periodic but comprehensive assessment of…”
    Get full text
    Journal Article
  2. 2

    Efficacy of terazosin in the treatment of essential hypertension in blacks by Luther, R R, Klepper, M J, Maurath, C J, Glassman, H N, Achari, R, Laddu, A R

    Published in Journal of human hypertension (01-04-1990)
    “…The antihypertensive effects of the selective alpha 1-adrenoceptor antagonist, terazosin, in black patients with uncomplicated, mild to moderate essential…”
    Get more information
    Journal Article
  3. 3

    Effects of terazosin on serum lipid levels in hypertensive blacks by Luther, R R, Klepper, M J, Maurath, C J, Glassman, H N, Achari, R, Laddu, A R

    Published in Journal of human hypertension (01-04-1990)
    “…The effects of terazosin, a new, selective, alpha 1-adrenoceptor antagonist, on the serum lipid levels were examined in 103 black patients with uncomplicated,…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent by Luther, R R, Glassman, H N, Jordan, D C, Klepper, M J

    Published in Journal of international medical research (01-01-1986)
    “…Seventy-two patients entered the treatment phase of an open, long-term, dose-ranging trial of carteolol in stable, exercise-induced angina pectoris. Patients…”
    Get more information
    Journal Article
  6. 6

    Carteolol treatment of essential hypertension: a long-term study of safety and efficacy by Luther, R R, Maurath, C J, Klepper, M J, Peckinpaugh, R O, Ringham, G L

    Published in Journal of international medical research (01-01-1986)
    “…The long-term safety and antihypertensive efficacy of carteolol were evaluated in an open-label, multicenter trial of 245 hypertensive patients. For those…”
    Get more information
    Journal Article